Peter Mattingly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter Mattingly has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Agustin Bengolea
Hospital Alemán, Buenos Aires, Argentina
1 shared publicationAlanood Alnuaimi
Primary Healthcare Sector, Dubai Health, Dubai, UAE
1 shared publication- Aleksandar Gavrancic
Mayo Clinic Volunteer Program, Department of Hospital Medicine, Mayo Clinic, Jacksonville, FL 32224, USA
1 shared publication Amit Kumar
Department of Laboratory Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
1 shared publication- Anja Fog Heen
Department of Medicine Lovisenberg Diaconal Hospital Oslo Norway
1 shared publication - Ariel Izcovich
Hospital Alemán, Buenos Aires, Argentina
1 shared publication
Latest Publications
- Open Access
- 31 July 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (2) , e001692
Clinicians’ decisions about antibiotic treatment in advanced dementia: an international survey
Objectives: In patients living with advanced dementia, the intensity of care during life-threatening infections remains controversial and marked by wide variation in practice. This international survey investigated physicians’ and physicians-in-training’s management choices for individuals with advanced dementia and the factors associated with those choices. Design: Vignette-based survey. Setting: Twelve countries across five continents. Methods: We administered our vignette-based survey to medical students, residents and physicians. The survey elicited participants’ views on whether antibiotics should be administered to an elderly patient with advanced dementia and very poor quality of life, presenting with bacterial pneumonia. We explored factors associated with treatment choices using univariable analysis and multiple logistic regression models. Results: Of the 785 participants (age, mean (SD): 31.1 (11.5) years), one-third (31.2%) resided in the Region of the Americas, 21.9% in Europe, 16.2% in the Eastern Mediterranean region and 17.1% in China. In the univariable analysis, choice to treat was associated with younger age, country/WHO region (African region highest overall, European region lowest overall), stage of medical training (medical student most inclined to treat) and absence of medical assistance in dying (MAiD) legislation. Multivariable analyses provided evidence that country was the variable most strongly associated with the choice to treat with antibiotics (Cameroon, China, Saudi Arabia highest; Norway, Switzerland, Spain lowest), with the presence of MAiD legislation also strongly associated (OR 0.35, 95% CI 0.23 to 0.51). Age (OR 0.82, 95% CI 0.66 to 1.00) and religiosity level (OR 0.93, 95% CI 0.87 to 0.99) showed weaker associations with treatment decisions. Conclusion: Inclination to treat individuals with advanced dementia who develop pneumonia varies greatly between and within jurisdictions. Social factors (in particular country but also presence of MAiD legislation) proved the most prominent associations, with individual characteristics much less influential. These findings underscore the importance of contextual and cultural factors in value-sensitive clinical decisions. Registration: We registered the protocol at Open Science Framework (osf.io/6kfbt).
- 31 July 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (2) , e001692
Open AccessClinicians’ decisions about antibiotic treatment in advanced dementia: an international survey
Objectives: In patients living with advanced dementia, the intensity of care during life-threatening infections remains controversial and marked by wide variation in practice. This international survey investigated physicians’ and physicians-in-training’s management choices for individuals with advanced dementia and the factors associated with those choices. Design: Vignette-based survey. Setting: Twelve countries across five continents. Methods: We administered our vignette-based survey to medical students, residents and physicians. The survey elicited participants’ views on whether antibiotics should be administered to an elderly patient with advanced dementia and very poor quality of life, presenting with bacterial pneumonia. We explored factors associated with treatment choices using univariable analysis and multiple logistic regression models. Results: Of the 785 participants (age, mean (SD): 31.1 (11.5) years), one-third (31.2%) resided in the Region of the Americas, 21.9% in Europe, 16.2% in the Eastern Mediterranean region and 17.1% in China. In the univariable analysis, choice to treat was associated with younger age, country/WHO region (African region highest overall, European region lowest overall), stage of medical training (medical student most inclined to treat) and absence of medical assistance in dying (MAiD) legislation. Multivariable analyses provided evidence that country was the variable most strongly associated with the choice to treat with antibiotics (Cameroon, China, Saudi Arabia highest; Norway, Switzerland, Spain lowest), with the presence of MAiD legislation also strongly associated (OR 0.35, 95% CI 0.23 to 0.51). Age (OR 0.82, 95% CI 0.66 to 1.00) and religiosity level (OR 0.93, 95% CI 0.87 to 0.99) showed weaker associations with treatment decisions. Conclusion: Inclination to treat individuals with advanced dementia who develop pneumonia varies greatly between and within jurisdictions. Social factors (in particular country but also presence of MAiD legislation) proved the most prominent associations, with individual characteristics much less influential. These findings underscore the importance of contextual and cultural factors in value-sensitive clinical decisions. Registration: We registered the protocol at Open Science Framework (osf.io/6kfbt).
- 10 July 2026
- Published by Wiley in Journal of Hospital Medicine
Beyond the “difficult patient”: Relational acuity as a dimension of clinical care
Hospitalists routinely encounter episodes of relational strain marked by distrust, frustration, escalating emotion, or misaligned expectations. Often labeled “difficult” encounters, these interactions are better understood as dynamic relational states that can disrupt communication, erode therapeutic alignment, and complicate care. In this perspective piece, we propose the construct of relational acuity : a clinical lens for recognizing moments of heightened relational strain that signal increased relational need. We introduce a practical four‐part framework: Recognition, Regulation, Realignment, and Repair, to help clinicians identify these encounters early, respond intentionally, and preserve the therapeutic relationship and the trajectory of care.
- 10 July 2026
- Published by Wiley in Journal of Hospital Medicine
Beyond the “difficult patient”: Relational acuity as a dimension of clinical care
Hospitalists routinely encounter episodes of relational strain marked by distrust, frustration, escalating emotion, or misaligned expectations. Often labeled “difficult” encounters, these interactions are better understood as dynamic relational states that can disrupt communication, erode therapeutic alignment, and complicate care. In this perspective piece, we propose the construct of relational acuity : a clinical lens for recognizing moments of heightened relational strain that signal increased relational need. We introduce a practical four‐part framework: Recognition, Regulation, Realignment, and Repair, to help clinicians identify these encounters early, respond intentionally, and preserve the therapeutic relationship and the trajectory of care.
- 1 July 2026
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 5 (7)
Racemose Neurocysticercosis Presenting as Subarachnoid Hemorrhage Mimic
- 1 July 2026
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 5 (7)
Racemose Neurocysticercosis Presenting as Subarachnoid Hemorrhage Mimic
- Open Access
- 20 June 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (3) , 62
Cardiovascular Complications of Anaplasmosis: A Case of Acute Pulmonary Embolism and Literature Review
Background: Anaplasmosis is an emerging tick-borne infection that typically presents as a non-specific febrile illness, with variable degrees of cytopenias and liver tests abnormalities. Severe complications remain atypical and uncommon. Case Report: We report a case of acute pulmonary embolism (PE) occurring during confirmed anaplasmosis in a 73-year-old male with no traditional thromboembolic risk factors. The patient presented with fever, constitutional symptoms, thrombocytopenia, leukopenia, and abnormal liver tests, raising suspicion for a tick-borne illness. Despite early clinical improvement on doxycycline, persistent tachycardia triggered further evaluation and uncovered an acute PE. Comprehensive workup at admission and repeated 14 months later excluded inherited and acquired thrombophilias, malignancies, autoimmune diseases, and alternative infectious etiologies. The patient was treated with doxycycline 100 mg orally twice daily for 10 days and anticoagulation with unfractionated heparin followed by 6 months of apixaban for a first episode of provoked PE. He attained complete clinical recovery without recurrence of thrombosis at the two-year follow-up. Discussion: Infectious diseases are increasingly recognized as contributors to thrombosis through inflammation-mediated hypercoagulability and endothelial dysfunction. Pulmonary involvement in anaplasmosis typically manifests as pneumonitis, pneumonia or acute respiratory distress syndrome, but thrombotic complications such as PE are exceedingly rare. This case highlights a rare but clinically significant vascular complication of anaplasmosis and underscores the importance of considering thromboembolic events in patients with persistent or unexplained tachycardia. Conclusions: As the incidence of anaplasmosis continues to rise, greater awareness of its potential cardiovascular manifestations is essential. Early recognition and prompt treatment with doxycycline remain critical, while further studies are needed to better define the thrombotic risk associated with this infection.
- 20 June 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (3) , 62
Open AccessCardiovascular Complications of Anaplasmosis: A Case of Acute Pulmonary Embolism and Literature Review
Background: Anaplasmosis is an emerging tick-borne infection that typically presents as a non-specific febrile illness, with variable degrees of cytopenias and liver tests abnormalities. Severe complications remain atypical and uncommon. Case Report: We report a case of acute pulmonary embolism (PE) occurring during confirmed anaplasmosis in a 73-year-old male with no traditional thromboembolic risk factors. The patient presented with fever, constitutional symptoms, thrombocytopenia, leukopenia, and abnormal liver tests, raising suspicion for a tick-borne illness. Despite early clinical improvement on doxycycline, persistent tachycardia triggered further evaluation and uncovered an acute PE. Comprehensive workup at admission and repeated 14 months later excluded inherited and acquired thrombophilias, malignancies, autoimmune diseases, and alternative infectious etiologies. The patient was treated with doxycycline 100 mg orally twice daily for 10 days and anticoagulation with unfractionated heparin followed by 6 months of apixaban for a first episode of provoked PE. He attained complete clinical recovery without recurrence of thrombosis at the two-year follow-up. Discussion: Infectious diseases are increasingly recognized as contributors to thrombosis through inflammation-mediated hypercoagulability and endothelial dysfunction. Pulmonary involvement in anaplasmosis typically manifests as pneumonitis, pneumonia or acute respiratory distress syndrome, but thrombotic complications such as PE are exceedingly rare. This case highlights a rare but clinically significant vascular complication of anaplasmosis and underscores the importance of considering thromboembolic events in patients with persistent or unexplained tachycardia. Conclusions: As the incidence of anaplasmosis continues to rise, greater awareness of its potential cardiovascular manifestations is essential. Early recognition and prompt treatment with doxycycline remain critical, while further studies are needed to better define the thrombotic risk associated with this infection.